Vestre Viken Hospital Trust

• Reconsidering Long-Term Apirin in the Elderly in Secondary Prevention of Coronary Artery Disease Norway

  Phase 4, Not yet recruiting, 7,000 people, 2 Oct 2026

• NCT06162013

  Collaborator, Phase 2, Recruiting, 330 people, 8 Dec 2023

• NCT05431257

  Collaborator, Phase 2, Recruiting, 117 people, 24 Jun 2022

• NCT05344209

  Phase 2, Recruiting, 138 people, 25 Apr 2022

• NCT05163106

  Collaborator, Phase 2, Completed, 85 people, 20 Dec 2021

• NCT05025293

  Collaborator, Phase 4, Completed, 228 people, 27 Aug 2021

• NCT04662866

  Collaborator, Phase 2, Status unknown, 64 people, 10 Dec 2020

• NCT04303026

  Phase 3, Status unknown, 70 people, 10 Mar 2020

• NCT03874156

  Phase 4, Completed, 77 people, 14 Mar 2019

• NCT03796650

  Collaborator, Phase 3, Terminated, 104 people, 8 Jan 2019

Sources: clinicaltrials.gov